Kirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, Christian Poulsen, Charlotta D. de la Cour, Trine Ryberg Clausen, Ann Maria Kruse Hansen, Linu M. John, Annette Plesner, Gao Sun, Morten Schlein, Rikke Bjerring Skyggebjerg, Thomas Kruse
{"title":"Correction to “NN1213 – A Potent, Long-Acting, and Selective Analog of Human Amylin”","authors":"Kirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, Christian Poulsen, Charlotta D. de la Cour, Trine Ryberg Clausen, Ann Maria Kruse Hansen, Linu M. John, Annette Plesner, Gao Sun, Morten Schlein, Rikke Bjerring Skyggebjerg, Thomas Kruse","doi":"10.1021/acs.jmedchem.4c02359","DOIUrl":null,"url":null,"abstract":"<i>Correction</i>: The following paragraph previously on page 11691 is now the footnote for Table 12 on page 11693. “Data are mean ± SEM measured as percent food intake relative to vehicle in rats after a single sc injection of 30 nmol/kg of the test substance. Data for cagrilintide have been published previously<sup>7</sup> giving rise to 85% and 84% reduction of food intake in the periods from 0–24 h and 24–48 h, respectively. SEM is the standard error of the mean.” <i>Correction:</i> The following paragraph was previously included as the footnotes for Table 9 on page 11692 and has been moved to page 11691. “From the in vitro data (Tables 10 and 11), it was apparent that selectivity was achieved for several peptides (<b>10</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, <b>18</b>, <b>20</b>, and <b>21</b>). From the ThT assay (Table 9 and Supporting Information), only three of the AMYR selective peptides (<b>14</b>, <b>16</b>, and <b>21</b>) were able to resist physical stress for more than 40 h. Two peptides (<b>15</b> and <b>21</b>) had a selectivity ratio above 30. Peptide 6 and peptides <b>11</b>–<b>21</b> with neutral/high pI were chosen for further evaluation in vivo to evaluate their ability to reduce food intake in rats after a single administration and to have increased insights into the duration of effects from the peptides in vivo (Table 11).” This article has not yet been cited by other publications.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"30 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c02359","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Correction: The following paragraph previously on page 11691 is now the footnote for Table 12 on page 11693. “Data are mean ± SEM measured as percent food intake relative to vehicle in rats after a single sc injection of 30 nmol/kg of the test substance. Data for cagrilintide have been published previously7 giving rise to 85% and 84% reduction of food intake in the periods from 0–24 h and 24–48 h, respectively. SEM is the standard error of the mean.” Correction: The following paragraph was previously included as the footnotes for Table 9 on page 11692 and has been moved to page 11691. “From the in vitro data (Tables 10 and 11), it was apparent that selectivity was achieved for several peptides (10, 14, 15, 16, 17, 18, 20, and 21). From the ThT assay (Table 9 and Supporting Information), only three of the AMYR selective peptides (14, 16, and 21) were able to resist physical stress for more than 40 h. Two peptides (15 and 21) had a selectivity ratio above 30. Peptide 6 and peptides 11–21 with neutral/high pI were chosen for further evaluation in vivo to evaluate their ability to reduce food intake in rats after a single administration and to have increased insights into the duration of effects from the peptides in vivo (Table 11).” This article has not yet been cited by other publications.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.